Aubrey Rankin, President, Innovation & Technology at Revance Therapeutics, Inc. (RVNC), sold 23,677 shares at $26.34 ($622K) on 2021-08-16, disclosed to the SEC on 2021-08-17.
Open-market sale of $622k RVNC by President, Innovation & Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.02 | 4,949 | $129K | 20.7% |
| 2 | $26.34 | 9,364 | $247K | 39.6% |
| 3 | $26.34 | 9,364 | $247K | 39.6% |
| Total | $26.27 avg | 23,677 | $622K | 100% |
| Filing → |
| RVNC | SELL | 2021-07-28 | $3.3M | — | Filing → |
| RVNC | SELL | 2021-04-06 | $57 | — | Filing → |
| RVNC | SELL | 2021-03-05 | $1.7M | — | Filing → |